InvestorsHub Logo
Followers 27
Posts 3416
Boards Moderated 0
Alias Born 07/17/2006

Re: vanessapu post# 116855

Saturday, 03/16/2013 8:56:26 PM

Saturday, March 16, 2013 8:56:26 PM

Post# of 346052
Apparently, MOS data in front line trials is difficult to determine as some patients go on to second line trials. So, I don't know what to expect from Peregrine's front line NSCLC trial. We could really use some impressive results. If we get them, maybe a return to better SPs is possible.

More waiting, sigh.

Paul
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News